Detalles de la búsqueda
1.
Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA.
Int J Mol Sci
; 25(8)2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38673836
2.
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
Br J Cancer
; 129(1): 135-142, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137997
3.
Methylated Cell-Free Tumor DNA in Sputum as a Tool for Diagnosing Lung Cancer-A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 16(3)2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339257
4.
Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy.
Sci Rep
; 14(1): 8993, 2024 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637655
5.
Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 15(15)2023 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568774
6.
Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohort.
Cancer Biomark
; 36(1): 63-69, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404535
7.
Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer-A Systematic Review.
Cancers (Basel)
; 14(9)2022 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565384
8.
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients.
J Int Med Res
; 50(6): 3000605221108924, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35770523
9.
The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer.
Transl Lung Cancer Res
; 10(2): 855-865, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33718027
Resultados
1 -
9
de 9
1
Próxima >
>>